Hepion Pharmaceuticals | Results Presentation Deck | 34 slides

Hepion Pharmaceuticals · 2022-10
arc beats above · slides in the middle · loops below · scroll → 0 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

1
coverage by narrative range · generated from this deck JSON
Narrative range 34 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Whole deck 34 slides 100% 34/34 slides 100% 34/34 slides · 138 hits
0/34 slides
41.2% 14/34 slides · 17 hits 32.4% 11/34 slides
0/34 slides
0/34 slides

Slide inventory

34
every slide · same image gating as the playbook
01
Slide 1
Includes company logo, ticker symbol, date, and a thematic illustration of a therapeutic ecosystem.front_matter
03
present_solution
04
Includes a bar chart of clinical trials by mechanism, a pie chart of organ distribution, and a stacked bar chart of trials over time.size_opportunity
05
The diagram uses a bullseye/concentric circle framework to show the hierarchy from disease down to the molecular level.frame_problem
06
The slide uses a numbered process flow to map the stages of collagen production, highlighting specific steps where CypB is involved using red circles.present_solution
07
The slide uses a three-part visual breakdown to map drug targets to therapeutic outcomes.present_solution
08
The slide uses a callout bubble to emphasize the consistency of findings across all listed models.show_traction
09
The chart uses a horizontal bar format to represent clinical trial stages for different medical conditions.plan_implementation
10
transition
11
The slide uses a process diagram to show disease progression and three columns to define the specific conditions.frame_problem
12
frame_problem
13
transition
14
The slide uses a process-style arrow diagram to represent the sequence of Phase 1 study components.show_traction
15
transition
16
The slide outlines a 42-day study timeline with a 28-day treatment period.plan_implementation
17
The slide presents clinical trial outcomes for a pharmaceutical asset.show_traction
18
transition
19
The diagram uses a brain visualization to represent the integration of AI technologies into the central AI-POWR platform.present_solution
20
Uses a funnel diagram to represent the filtering of patient data into responders and non-responders.present_solution
21
The slide uses a network graph to visualize gene interactions, categorized by color-coded functional groups.show_traction
22
transition
23
The slide outlines a randomized clinical trial structure with a 1:1:1:1 ratio, a 12-month treatment period, and a 1-month follow-up.plan_implementation
24
The slide defines the success criteria for the trial based on liver histology improvements.analyze_data
25
transition
26
The slide outlines a randomized clinical trial structure with three dosing arms and a follow-up period.plan_implementation
27
analyze_data
28
transition
29
Includes specific stopping rules for futility based on Disease Control Rate (DCR).plan_implementation
30
transition
31
Uses a Venn diagram to show the intersection of three core strategic pillars.present_solution
32
Slide 32 of the deck.summarize
34
state_next_steps